Structural elements regulating amyloidogenesis: A cholinesterase model system

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Jean, Létitia ^a   Lee, Chiu Fan ^b   Shaw, Michael ^a   Vaux, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME STRUCTURE; HYDROPHOBICITY; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; OLIGOMERIZATION; PATHOGENESIS; POINT MUTATION; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FOLDING; STEREOSPECIFICITY; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; AMYLOID; BLOTTING, WESTERN; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 46649120114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001834     Document Type: Article

References (75)

1. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385-407.
2. Westermark P (2005) Aspects on human amyloid forms and their fibril polypeptides. Febs J 272: 5942-5949.
3. Klunk WE, Pettegrew JW, Abraham DJ (1989) Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 37: 1273-1281.
4. LeVine H 3rd (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2: 404-410.
5. Rochet JC, Lansbury PT Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10: 60-68.
6. Sipe JD, Cohen AS (2000) Review: history of the amyloid fibril. J Struct Biol 130: 88-98.
7. Smith CK, Regan L (1995) Guidelines for protein design: the energetics of beta sheet side chain interactions. Science 270: 980-982.
8. West MW, Wang W, Patterson J, Mancias JD, Beasley JR, et al. (1999) De novo amyloid proteins from designed combinatorial libraries. Proc Natl Acad Sci U S A 96: 11211-11216.
9. Klimov DK, Thirumalai D (2003) Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure 11: 295-307.
10. Zanuy D, Haspel N, Tsai HH, Ma B, Gunasekaran K, et al. (2004) Side chain interactions determine the amyloid organization: a single layer beta-sheet molecular structure of the calcitonin peptide segment 15-19. Phys Biol 1: 89-99.
11. Azriel R, Gazit E (2001) Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem 276: 34156-34161.
12. Massi F, Klimov D, Thirumalai D, Straub JE (2002) Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant. Protein Sci 11: 1639-1647.
13. Reches M, Porat Y, Gazit E (2002) Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 277: 35475-35480.
14. Bitan G, Vollers SS, Teplow DB (2003) Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem 278: 34882-34889.
15. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC (2005) Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci U S A 102: 315-320.
16. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
17. Atwood CS, Martins RN, Smith MA, Perry G (2002) Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides 23: 1343-1350.
18. Saez-Valero J, Sberna G, McLean CA, Small DH (1999) Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J Neurochem 72: 1600-1608.
19. Rees TM, Berson A, Sklan EH, Younkin L, Younkin S, et al. (2005) Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr Alzheimer Res 2: 291-300.
20. Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O, et al. (2006) Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci U S A 103: 8628-8633.
21. Cottingham MG, Hollinshead MS, Vaux DJ (2002) Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Biochemistry 41: 13539-13547.
22. Yoon S, Welsh WJ (2004) Detecting hidden sequence propensity for amyloid fibril formation. Protein Sci 13: 2149-2160.
23. Cottingham MG, Voskuil JL, Vaux DJ (2003) The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Biochemistry 42: 10863-10873.
24. Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ (2007) Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. PLoS ONE 2: e652.
25. Jack E, Newsome M, Stockley PG, Radford SE, Middleton DA (2006) The organization of aromatic side groups in an amyloid fibril probed by solid-state 2H and 19F NMR spectroscopy. J Am Chem Soc 128: 8099-8099.
26. Tjernberg LO, Naslund J, Lindqvist F, Johansson J, Karlstrom AR, et al. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271: 8545-8548.
27. Kuner P, Bohrmann B, Tjernberg LO, Naslund J, Huber G, et al. (2000) Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands. J Biol Chem 275: 1673-1678.
28. Soreghan B, Kosmoski J, Glabe C (1994) Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. J Biol Chem 269: 28551-28554.
29. Cottingham MG, Bain CD, Vaux DJ (2004) Rapid method for measurement of surface tension in multiwell plates. Lab Invest 84: 523-529.
30. Fancy DA, Kodadek T (1999) Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A 96: 6020-6024.
31. Seilheimer B, Bohrmann B, Bondolfi L, Muller F, Stuber D, et al. (1997) The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119: 59-71.
32. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. (2002) Alphasynuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-1102.
33. Lopez de la Paz M, Serrano L (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A 101: 87-92.
34. Lopez de la Paz M, de Mori GM, Serrano L, Colombo G (2005) Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. J Mol Biol 349: 583-596.
35. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, et al. (2002) A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A 99: 16742-16747.
36. Tjernberg L, Hosia W, Bark N, Thyberg J, Johansson J (2002) Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem 277: 43243-43246.
37. Tarus B, Straub JE, Thirumalai D (2005) Probing the initial stage of aggregation of the Abeta(10-35)-protein: assessing the propensity for peptide dimerization. J Mol Biol 345: 1141-1156.
38. Zhang S, Holmes T, Lockshin C, Rich A (1993) Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A 90: 3334-3338.
39. Wouters MA, Curmi PM (1995) An analysis of side chain interactions and pair correlations within antiparallel beta-sheets: the differences between backbone hydrogen-bonded and non-hydrogen-bonded residue pairs. Proteins 22: 119-131.
40. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, et al. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4: 887-893.
41. Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, et al. (2000) Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295: 1055-1071.
42. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808.
43. Gazit E (2002) A possible role for pi-stacking in the self-assembly of amyloid fibrils. Faseb J 16: 77-83.
44. Claessens CG, Stoddart JF (1997) p-p interactions in self-assembly. J Phys Org Chem 10: 254-272.
45. Gillard RE, Raymo FM, Stoddart JF (1997) Controlling self-assembly. Chem Eur J 3: 1933-1940.
46. Waters ML (2002) Aromatic interactions in model systems. Curr Opin Chem Biol 6: 736-741.
47. Wu C, Lei H, Duan Y (2005) The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys J 88: 2897-2906.
48. Bemporad F, Taddei N, Stefani M, Chiti F (2006) Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci 15: 862-870.
49. Sikorski P, Atkins ED, Serpell LC (2003) Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment. Structure 11: 915-926.
50. Naito A, Kamibira M, Inoue R, Saito H (2004) Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn Reson Chem 42: 247-257.
51. Shetty AS, Zhang J, Moore JS (1996) Aromatic -p Stacking in Solution as Revealed through the Aggregation of Phenylacetylene Macrocycles. J Am Chem Soc 118: 1019-1027.
52. McGaughey GB, Gagne M, Rappe AK (1998) pi-Stacking interactions. Alive and well in proteins. J Biol Chem 273: 15458-15463.
53. Lin TY, Timasheff SN (1996) On the role of surface tension in the stabilization of globular proteins. Protein Sci 5: 372-381.
54. Crowley PB, Golovin A (2005) Cation-pi interactions in protein-protein interfaces. Proteins 59: 231-239.
55. Paddock ML, Weber KH, Chang C, Okamura MY (2005) Interactions between cytochrome c2 and the photosynthetic reaction center from Rhodobacter sphacroides: the cation-pi interaction. Biochemistry 44: 9619-9625.
56. Ma JC, Dougherty DA (1997) The Cationminus signpi Interaction. Chem Rev 97: 1303-1324.
57. Chakkaravarthi S, Gromiha MM (2006) Analysis of cation π interactions to the structural stability of RNA binding proteins. Polymer 47: 709-721.
58. Yoshida H, Matsushima N, Kumaki Y, Nakata M, Hikichi K (2000) NMR studies of model peptides of PHGGGWGQ repeats within the N-terminus of prion proteins: a loop conformation with histidine and tryptophan in close proximity. J Biochem (Tokyo) 128: 271-281.
59. Zahn R (2003) The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site. J Mol Biol 334: 477-488.
60. Pal D, Chakrabarti P (2001) Non-hydrogen bond interactions involving the methionine sulfur atom. J Biomol Struct Dyn 19: 115-128.
61. Samanta U, Pal D, Chakrabarti P (2000) Environment of tryptophan side chains in proteins. Proteins 38: 288-300.
62. Petkova AT, Yau WM, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45: 498-512.
63. Kellis JT Jr, Todd RJ, Arnold FH (1991) Protein stabilization by engineered metal chelation. Biotechnology (N Y) 9: 994-995.
64. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, et al. (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273: 12817-12826.
65. Lin ST, Howlett G, Barrow CJ (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38: 9373-9378.
66. Miura T, Suzuki K, Kohata N, Takeuchi H (2000) Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39: 7024-7031.
67. Yang DS, McLaurin J, Qin K, Westaway D, Fraser PE (2000) Examining the zinc binding site of the amyloid-beta peptide. Eur J Biochem 267: 6692-6698.
68. Jones CE, Abdelraheim SR, Brown DR, Viles JH (2004) Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J Biol Chem 279: 32018-32027.
69. Salemme FR, Weatherford DW (1981) Conformational and geometrical properties of beta-sheets in proteins. I. Parallel beta-sheets. J Mol Biol 146: 101-117.
70. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447: 453-457.
71. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci U S A 95: 4224-4228.
72. Fandrich M, Fletcher MA, Dobson CM (2001) Amyloid fibrils from muscle myoglobin. Nature 410: 165-166.
73. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81: 678-699.
74. Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698: 131-153.
75. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.